169 related articles for article (PubMed ID: 33284001)
21. H
Wang X; Jaraquemada-Peláez MG; Rodríguez-Rodríguez C; Cao Y; Buchwalder C; Choudhary N; Jermilova U; Ramogida CF; Saatchi K; Häfeli UO; Patrick BO; Orvig C
J Am Chem Soc; 2018 Nov; 140(45):15487-15500. PubMed ID: 30394734
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.
Schniering J; Borgna F; Siwowska K; Benešová M; Cohrs S; Hasler R; van der Meulen NP; Maurer B; Schibli R; Müller C
Mol Pharm; 2018 Nov; 15(11):4995-5004. PubMed ID: 30265552
[TBL] [Abstract][Full Text] [Related]
23. AAZTA
Sinnes JP; Nagel J; Rösch F
EJNMMI Radiopharm Chem; 2019 Aug; 4(1):18. PubMed ID: 31659525
[TBL] [Abstract][Full Text] [Related]
24. Isolation of a 177Hf complex formed by beta-decay of a 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes.
Cagnolini A; D'Amelio N; Metcalfe E; Nguyen HD; Aime S; Swenson RE; Linder KE
Inorg Chem; 2009 Apr; 48(7):3114-24. PubMed ID: 19243162
[TBL] [Abstract][Full Text] [Related]
25. Thermodynamic and kinetic study of scandium(III) complexes of DTPA and DOTA: a step toward scandium radiopharmaceuticals.
Pniok M; Kubíček V; Havlíčková J; Kotek J; Sabatie-Gogová A; Plutnar J; Huclier-Markai S; Hermann P
Chemistry; 2014 Jun; 20(26):7944-55. PubMed ID: 24838869
[TBL] [Abstract][Full Text] [Related]
26. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
[TBL] [Abstract][Full Text] [Related]
28. Solution Thermodynamics and Kinetics of Metal Complexation with a Hydroxypyridinone Chelator Designed for Thorium-227 Targeted Alpha Therapy.
Deblonde GJ; Lohrey TD; Booth CH; Carter KP; Parker BF; Larsen Å; Smeets R; Ryan OB; Cuthbertson AS; Abergel RJ
Inorg Chem; 2018 Nov; 57(22):14337-14346. PubMed ID: 30372069
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, structures, and electroluminescent properties of scandium N,O-chelated complexes toward near-white organic light-emitting diodes.
Katkova MA; Balashova TV; Ilichev VA; Konev AN; Isachenkov NA; Fukin GK; Ketkov SY; Bochkarev MN
Inorg Chem; 2010 Jun; 49(11):5094-100. PubMed ID: 20423054
[TBL] [Abstract][Full Text] [Related]
30. Emerging chelators for nuclear imaging.
Sneddon D; Cornelissen B
Curr Opin Chem Biol; 2021 Aug; 63():152-162. PubMed ID: 34051509
[TBL] [Abstract][Full Text] [Related]
31. [
Southcott L; Li L; Patrick BO; Stephan H; Jaraquemada-Peláez MG; Orvig C
Inorg Chem; 2021 Dec; 60(23):18082-18093. PubMed ID: 34788042
[TBL] [Abstract][Full Text] [Related]
32. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals.
Phipps MD; Cingoranelli S; Bhupathiraju NVSDK; Younes A; Cao M; Sanders VA; Neary MC; Devany MH; Cutler CS; Lopez GE; Saini S; Parker CC; Fernandez SR; Lewis JS; Lapi SE; Francesconi LC; Deri MA
Inorg Chem; 2023 Dec; 62(50):20567-20581. PubMed ID: 36724083
[TBL] [Abstract][Full Text] [Related]
33. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
34. Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions.
Kopp I; Cieslik P; Anger K; Josephy T; Neupert L; Velmurugan G; Gast M; Wadepohl H; Brühlmann SA; Walther M; Kopka K; Bachmann M; Stephan H; Kubeil M; Comba P
Inorg Chem; 2023 Dec; 62(50):20754-20768. PubMed ID: 37707798
[TBL] [Abstract][Full Text] [Related]
35. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
36. Functionally Versatile and Highly Stable Chelator for
Li L; Jaraquemada-Peláez MG; Kuo HT; Merkens H; Choudhary N; Gitschtaler K; Jermilova U; Colpo N; Uribe-Munoz C; Radchenko V; Schaffer P; Lin KS; Bénard F; Orvig C
Bioconjug Chem; 2019 May; 30(5):1539-1553. PubMed ID: 31009566
[TBL] [Abstract][Full Text] [Related]
37. A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
Osl T; Schmidt A; Schwaiger M; Schottelius M; Wester HJ
Theranostics; 2020; 10(18):8264-8280. PubMed ID: 32724470
[TBL] [Abstract][Full Text] [Related]
38. Marine Exopolysaccharide Complexed With Scandium Aimed as Theranostic Agents.
Mazza M; Alliot C; Sinquin C; Colliec-Jouault S; Reiller PE; Huclier-Markai S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672781
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic evaluation of the stability of the bone-seeking radiopharmaceutical [177Lu]Lu(III)-DOTP under simulated blood plasma conditions.
Sepini LC; Jarvis NV; Jansen DR; Zeevaart JR
Anal Chim Acta; 2012 Jun; 730():66-70. PubMed ID: 22632046
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.
Chong HS; Sun X; Chen Y; Sin I; Kang CS; Lewis MR; Liu D; Ruthengael VC; Zhong Y; Wu N; Song HA
Bioorg Med Chem; 2015 Mar; 23(5):1169-78. PubMed ID: 25648683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
